Skip to main content
Log in

Changes in Total Serum Glycosaminoglycan Levels in Patients Undergoing Renal Transplantation: Preliminary Data

  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

To study the involvement of glycosaminoglycans (GAGs) in the immunological process of renal disease. They are related to cytokines, which are known to play an important role in acute graft rejection after renal transplantation.

Methods

We studied 40 patients on maintenance hemodialysis for chronic renal failure, who underwent renal transplantation from a live donor. We measured serum GAGs preoperatively, intraoperatively, and on postoperative days (PODs) 2 and 10. The clinical outcome and other biochemical markers, such as blood urea nitrogen and serum creatinine, were also recorded.

Results

The total serum GAG levels decreased after renal transplantation in patients with normal graft function (group N). However, in patients with acute graft rejection post-transplantation (group R), the GAG levels remained significantly elevated.

Conclusions

Total serum GAGs fluctuate in renal transplantation and their association with graft rejection should be investigated further.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papaioannou, E., Magkou, C., Kostakis, A. et al. Changes in Total Serum Glycosaminoglycan Levels in Patients Undergoing Renal Transplantation: Preliminary Data. Surg Today 34, 668–672 (2004). https://doi.org/10.1007/s00595-004-2795-4

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-004-2795-4

Key words

Navigation